Search

everythinglearnresearchcommunity

for

Search:↓

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

Using these leaves to wrap corn-based foods in Togo is safe and boosts nutrition and preservation.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

Acyzol could help treat conditions caused by zinc deficiency.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Enhancing immune response can improve cancer treatment effectiveness.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.